CIGB-300 (P15-Tat)
Anti-CK2 cyclic cell-penetrating research peptide.
Oncology Research Peptides
Nelipepimut-S (E75) is a synthetic nonapeptide derived from the HER2/neu protein, studied as a research-grade immuno-oncology peptide within the HLA-A2/A3-restricted epitope research category. It is investigated for HER2-specific immune-response induction, CD8+ cytotoxic T-lymphocyte priming research, GM-CSF-adjuvanted formulation research, and antigen-specific T-cell response and epitope-spreading studies.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Anti-CK2 cyclic cell-penetrating research peptide.
Telomerase-derived 16-mer research peptide.
PSP-94-derived antitumor research peptide.